The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Operation Lifesaver campaigns to promote rail safety in 11 states
- New TD Crew Room Flyers Available
- Colorado bill criminalizing transit assault one step closer to becoming law
- Honoring the Legacy of Brother John A. Saunders
- Colorado Transit Worker Safety Bill (House Bill 25-1290)
- Kansas funds passenger rail expansion
- Maryland Passes Monumental Transit Safety Bill
- Brother Wirth Crowned Champion in 168-Pound Masters Division Victory
- Chairman Pauli Announces Retirement, SMART-TD celebrates his career
- New Mexico Local 1687 sets new precedent with Red Apple Transit